Navigation Links
VIA Pharmaceuticals' DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation
Date:6/4/2009

Preclinical Data Reported by Roche at 69th Scientific Sessions

SAN FRANCISCO, June 4 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, announced today that preclinical data related to diacylglycerol acyl transferase - 1 (DGAT1) inhibitors will be presented in a poster presentation at the 69th Scientific Sessions of the American Diabetes Association June 6, 2009 in New Orleans, LA. The poster will be presented by Roche (SWX: ROG), who licensed its DGAT1 inhibitors exclusively to VIA in December 2008. Dr. Rebecca Taub, Sr. Vice President Research & Development of VIA and a co-author on the poster, managed development of the DGAT1 program at Roche prior to joining the VIA management team.

    The presentation details are as follows:
       Date/Time: Saturday June 6, 2009
                  11:30AM - 1:30PM
                   6:15PM - 7:30PM
       Location: Ernest N. Morial Convention Center
       Session: Insulin Action - Metabolism
       Title: Can DGAT Inhibition Improve Insulin Sensitivity? (Poster 1279-P)

DGAT1 (diacylglycerol acyl transferase-1) is an enzyme that catalyzes triglyceride synthesis and fat storage. Triglycerides are the principal component of fat, which is the major repository for storage of metabolic energy in the body. Overweight and obese individuals have significantly greater triglyceride levels, making them more prone to diabetes and its associated metabolic complications. DGAT1 inhibitors are believed to be an innovative class of compounds that modify lipid metabolism. In studies of obese animals, DGAT1 inhibitors have been shown to induce weight loss and improve insulin sensitization, glucose tolerance and lipid levels. These obs
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Optimer Pharmaceuticals to Present at June 2009 Investor Conferences
2. Amylin Pharmaceuticals to Present at Goldman Sachs Annual Global Health Care Conference
3. Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI
4. Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
5. Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting
6. Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study
7. OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer
8. OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial
9. Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system
10. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
11. OncoGenex Pharmaceuticals to Webcast ASCO Reception on May 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... May 22 Amsterdam,Molecular Therapeutics (Euronext: AMT), ... gene,therapy, today announced that it obtained a ... to their advanced small nuclear RNA,(snRNA)-based exon-skipping ... (DMD). The combination with AMT,s proprietary,adeno-associated virus ...
... you, but to Hemant Jain they are the first steps ... the University of WisconsinMilwaukees Kenilworth Square Apartments, the appliances operate ... and dryers are available, and can opt to receive an ... that maintains the machines monitors them via the Internet. , ...
... Abstracts Accepted for Presentation at ASCO, SOUTH SAN FRANCISCO, ... today that it will hold an investor and,analyst briefing in ... Clinical Oncology (ASCO) from 6:00 p.m. to 8:00 p.m. CT,on ... A. Scangos, PhD, President and Chief Executive Officer -- ...
Cached Biology Technology:AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy 2AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy 3Better business decisions with real-time data 2Better business decisions with real-time data 3Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing 2Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing 3Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing 4
(Date:4/15/2014)... 15, 2014 New research, partially funded by the ... shows that consumers can improve their diets simply by ... daily meals. , In a study ... Nutrition Sciences , lead author Theresa Nicklas, DrPH, of ... Nutrition Examination Survey datasets from 2005-2010 and evaluated the ...
(Date:4/14/2014)... pill to swallow, but if you,re over 24 years ... of your cognitive motor performance, according to a new ... a psychology doctoral student, associate professor Mark Blair, Thompson,s ... science doctoral student, deliver the news in a just-published ... one of the first social science experiments to rest ...
(Date:4/14/2014)... - High levels of the greenhouse gas methane were ... not thought to be an important emissions source, according ... universities. The findings could have implications for the evaluation ... The study, which is one of only a few ... methane gas levels in the air above wells, identified ...
Breaking Biology News(10 mins):Eating rice boosts diet quality, reduces body weight and improves markers for health 2Eating rice boosts diet quality, reduces body weight and improves markers for health 3Study says we're over the hill at 24 2'Problem wells' source of greenhouse gas at unexpected stage of natural gas production 2
... immune system has been shown by study of one of the ... The microRNA acts as a lynchpin to balance the response of ... have a similar vital role. , Cells of the immune system ... cells and the mice develop symptoms similar to those of human ...
... a link between massive volcanic eruptions along the east coast ... million years ago and a period of global warming that ... tropics and more than six degrees in the Arctic. , ... , The study is important, experts say, because it ...
... valley adjacent to the Oak Ridge National Laboratory's Y-12 ... the facility between 1951 and 1983 leaches into groundwater ... contaminated site. , But soon, Florida State University ... team will help clean up the mess. , ...
Cached Biology News:Minuscule molecules pack a powerful punch 2Minuscule molecules pack a powerful punch 3Volcanic eruptions, ancient global warming linked 2Volcanic eruptions, ancient global warming linked 3'Hidden-hero' microbes in soil, water may help naturally clean toxic sites 2
... Combining linear motor and ballscrew ... pre-engineered Cartesian solutions that include ... management, and motors., , ... Pass through high-flex cabling for ...
UGT1A6 (D-20)...
... T Squareds patented high efficiency dynamic valve ... With the most compact, lightweight package in ... use in portable air and gas applications., ... high efficiency. , Includes DC Motor. ...
... designed for moving loads quickly and accurately. ... output while limiting overall size. The P5S-P ... ball bearings guided on two rails., ... provide energy absorption and controlled deceleration , ...
Biology Products: